Abstract
An Interim Analysis is a snapshot within a clinical trial that can occur to analyze available data in order to understand performance of a drug or device. Outcomes of an interim analysis can guide decision-making about next steps for a trial, including possible modifications or even stopping the trial if the drug or device is not meeting clinical objectives.
The Clinical Trial Manager (CTM) uses project leadership and management skills to coordinate constantly moving parts, communicate & collaborate with multiple stakeholders across organizations, address risks in a practical manner, and much more.
Join our speaker Tiffany Ashton, MAS, CCRA as she shares her expertise, experience and lessons learned in planning and conducting interim analyses, illustrated with a real-world case study.
Learning objectives:
By the end of this presentation, participants will understand the critical role of a Clinical Trial Manager during an interim analysis, including managing timelines, coordinating stakeholders, and ensuring data integrity, while gaining actionable insights from a real-world case study.
Registration
- $0.00 - PMINJ Chapter members
- $5.00 - Non-members (no refund)
- The link to the virtual meeting will be included in
the Registration Receipt
- Download the Zoom app at: https://zoom.us/download
Speaker
Tiffany Ashton, MAS, CCRA
With over 21 years of experience working as a highly respected professional in the clinical research community, Tiffany has served various Clinical Research roles, including the last 10 years as a consultant in the Clinical Trial Manager/Project Manager role, but also has experience as a Clinical Research Coordinator, Clinical Research Associate (CRA), Unblinded CRA, Lead CRA, and Unblinded Clinical Trial Manager. Her firsthand industry experience is unlike others in the field. Tiffany strives to make a true and lasting impact and loves mentoring and teaching.
Tiffany is a seasoned Clinical Research Professional who has earned a BA from San Diego State University, a Masters of Advanced Studies in Clinical Research from the University of California, San Diego, an ACRP Certified Clinical Research Associate designation, and a Certificate in Clinical Trials Design and Management. In addition, she possesses an extensive list of therapeutic experience which include: Oncology, Rare Disease, Gene Therapy, CNS, Gastroenterology, Woman’s Health, and many others in Phase I through IV settings on the Study Sponsor and CRO side.
LinkedIn Profile: www.linkedin.com/in/tiffany-ashton-clinessentials
